Top compounds associated with response to EQTN


Feature Type Standardized
Nominal ANOVA
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.2 2e-09
mRNA etomoxir CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.1 0.003
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.095 0.004
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.096 0.005
Download CSV